Charles Large

USPTO Granted Patents = 12 (Patent Applications = 4)

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 42(Granted Patents)

Location History:

Stevenage, GB (2020 - 2021)
Verona, IT (2012 - 2023)

Company Filing History:

10 out of 25

Autifony Therapeutics Limited

Autifony Therapeuctics Limited

patent

Years Active: 2012-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11583527 - Hydantoin derivatives useful as Kv3 inhibitors (2023-02-21),

2. 11197859 - Hydantoin derivatives useful as Kv3 inhibitors (2021-12-14),

3. 11147813 - Modulators of KV3 channels to treat pain (2021-10-19),

4. 10632118 - Imidazolidinedione derivatives (2020-04-28),

5. 10265316 - Hydantoin derivatives useful as Kv3 inhibitors (2019-04-23),

6. 10058551 - Imidazolidinedione derivatives (2018-08-28),

7. 9849131 - Imidazolidinedione derivatives (2017-12-26),

8. 9669030 - Hydantoin derivatives as Kv3 inhibitors (2017-06-06),

9. 9346790 - Hydantoin derivatives useful as Kv3 inhibitors (2016-05-24),

10. 9216967 - Imidazolidinedione derivatives (2015-12-22),

11. 8722695 - Imidazolidinedione derivatives (2014-05-13),

12. 8093268 - Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-) (2012-01-10),

Title: The Innovative Journey of Inventor Charles Large

Introduction: Inventor Charles Large, hailing from Verona, IT, has made a significant impact in the realm of innovation and patents. With a portfolio boasting 12 patents, his dedication to pushing technological boundaries is truly commendable.

Latest Patents: Charles Large's latest patents showcase his prowess in the field. One notable invention is the "Hydantoin derivatives useful as Kv3 inhibitors," which presents compounds that are pivotal in inhibiting Kv3 channels for the prophylaxis and treatment of related disorders.

Career Highlights: Charles Large has lent his inventive skills to renowned companies such as Autifony Therapeutics Limited and Glaxo Group Limited. His innovative contributions have undoubtedly enhanced the technological landscape within these organizations.

Collaborations: Throughout his career, Charles Large has collaborated with esteemed individuals such as Giuseppe Alvaro and Agostino Marasco. These partnerships have fostered a dynamic environment for the exchange of groundbreaking ideas and inventive solutions.

Conclusion: Charles Large epitomizes the spirit of innovation and perseverance. His unwavering commitment to creating a better future through technology shines through in his numerous patents and collaborative efforts. Charles Large's legacy serves as an inspiration to aspiring inventors and underscores the profound impact of innovation on society.

This text is generated by artificial intelligence and may not be accurate.